Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PARKHOMENKO, Alexander")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 20 of 20

  • Page / 1
Export

Selection :

  • and

Implication of the B → (ρ, ω) γ branching ratios for the CKM phenomenologyALI, Ahmed; LUNGHI, Enrico; PARKHOMENKO, Alexander Ya et al.Physics letters. Section B. 2004, Vol 595, Num 1-4, pp 323-338, issn 0370-2693, 16 p.Article

Metabolic remodeling as a target preventing myocardial dysfunction: focus on trimetazidinePARKHOMENKO, Alexander N; GURJEVA, Olga S.Heart and metabolism. 2014, Num 62, pp 22-26, issn 1566-0338, 5 p.Article

Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and designSHIBATA, Marcelo C; FLATHER, Marcus D; TAVAZZI, Luigi et al.International journal of cardiology. 2002, Vol 86, Num 1, pp 77-85, issn 0167-5273Article

Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendanPAPP, Zoltán; EDES, Istvan; MORELLI, Andrea et al.International journal of cardiology. 2012, Vol 159, Num 2, pp 82-87, issn 0167-5273, 6 p.Article

Darapladib for Preventing Ischemic Events in Stable Coronary Heart DiseaseWHITE, Harvey D; HELD, Claes; ARMSTRONG, Paul W et al.The New England journal of medicine. 2014, Vol 370, Num 18, pp 1702-1711, issn 0028-4793, 10 p.Article

Renal Effects of Levosimendan: A Consensus ReportYILMAZ, Mehmet B; GROSSINI, Elena; MORELLI, Andrea et al.Cardiovascular drugs and therapy. 2013, Vol 27, Num 6, pp 581-590, issn 0920-3206, 10 p.Article

Apixaban in Patients with Atrial FibrillationCONNOLLY, Stuart J; EIKELBOOM, John; TALAJIC, Mario et al.The New England journal of medicine. 2011, Vol 364, Num 9, pp 806-817, issn 0028-4793, 12 p.Article

Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromesMEBAZAA, Alexandre; GHEORGHIADE, Mihai; KOMAJDA, Michel et al.Critical care medicine. 2008, Vol 36, Num 1, issn 0090-3493, S129-S139, SUPArticle

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsRUFF, Christian T; GIUGLIANO, Robert P; YAMASHITA, Takeshi et al.Lancet (British edition). 2014, Vol 383, Num 9921, pp 955-962, issn 0140-6736, 8 p.Article

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012MCMURRAY, John J. V; ADAMOPOULOS, Stamatis; JAARSMA, Tiny et al.European heart journal. 2012, Vol 33, Num 14, pp 1787-1847, issn 0195-668X, 61 p.Article

Apixaban with Antiplatelet Therapy after Acute Coronary SyndromeALEXANDER, John H; LOPES, Renato D; HUBER, Kurt et al.The New England journal of medicine. 2011, Vol 365, Num 8, pp 699-708, issn 0028-4793, 10 p.Article

History of Hypertension and Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure. CommentaryRUILOPE, Luis M; PITT, Bertram; SOLOMON, Henry et al.Hypertension (Dallas, Tex. 1979). 2008, Vol 52, Num 2, issn 0194-911X, 207-208, 271-278 [10 p.]Article

Recommendations for the structure, organization, and operation of intensive cardiac care unitsHASIN, Yonathan; DANCHIN, Nicolas; WALLENTIN, Lars C et al.European heart journal. 2005, Vol 26, Num 16, pp 1676-1682, issn 0195-668X, 7 p.Article

Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction: Results From the ATLAS ACS-2―TIMI-51 Trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome― Thrombolysis In Myocardial Infarction-51)MEGA, Jessica L; BRAUNWALD, Eugene; MURPHY, Sabina A et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 18, pp 1853-1859, issn 0735-1097, 7 p.Article

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without RevascularizationROE, Matthew T; ARMSTRONG, Paul W; ARDISSINO, Diego et al.The New England journal of medicine. 2012, Vol 367, Num 14, pp 1297-1309, issn 0028-4793, 13 p.Article

Apixaban versus Warfarin in Patients with Atrial FibrillationGRANGER, Christopher B; ALEXANDER, John H; CECILIA BAHIT, M et al.The New England journal of medicine. 2011, Vol 365, Num 11, pp 981-992, issn 0028-4793, 12 p.Article

Dronedarone in High-Risk Permanent Atrial FibrillationCONNOLLY, Stuart J; CAMM, A. John; BUDAJ, Andrzej et al.The New England journal of medicine. 2011, Vol 365, Num 24, pp 2268-2276, issn 0028-4793, 9 p.Article

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. CommentarySARAFIDIS, Pantelis A; BAKRIS, George L; BUDAJ, Andrzej et al.Lancet (British edition). 2008, Vol 372, Num 9638, issn 0140-6736, 511-512, 547-553 [9 p.]Article

Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic : an ExTRACT-TIMI 25 analysisGIRALDEZ, Roberto R; NICOLAU, José Carlos; ANTMAN, Elliott M et al.European heart journal. 2007, Vol 28, Num 13, pp 1566-1573, issn 0195-668X, 8 p.Article

Global outcomes of ST-elevation myocardial infarction : Comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trialSTEINBERG, Benjamin A; MOGHBELI, Nazanin; MORROW, David A et al.The American heart journal. 2007, Vol 154, Num 1, pp 54-61, issn 0002-8703, 8 p.Article

  • Page / 1